Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. - Bergh,J.; Wiklund,T.; Erikstein,B. (Lancet, 2000)